Compare $SRPT vs $VIR | Chartloom

Compare

$SRPT vs $VIR

Sarepta Therapeutics Inc · Vir Biotechnology Inc

SRPT

Sarepta Therapeutics Inc

VIR

Vir Biotechnology Inc

Compare $SRPT vs $VIR

Comparing Sarepta Therapeutics Inc and Vir Biotechnology Inc

SRPTSarepta Therapeutics Inc

VIRVir Biotechnology Inc

SRPTSarepta Therapeutics Inc

Market cap

$1.88B

P/E (TTM)

—

Forward P/E (NTM)

46.80x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

-20.4%

YTD performance

-16.2%

52W performance

-23.7%

FCF yield

4.0%

VIRVir Biotechnology Inc

Market cap

$1.97B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

36.09x

Rev growth (TTM)

1496.1%

YTD performance

97.0%

52W performance

93.4%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SRPT

VIR

Detailed metrics comparison

SRPT

Sarepta Therapeutics Inc

VIR

Vir Biotechnology Inc

Market Cap

SRPT$1.88B

VIR$1.97B

Enterprise Value

SRPT$2.16B

VIR$1.69B

Price

SRPT$17.85

VIR$11.70

P/E Ratio

SRPTN/A

VIRN/A

P/S Ratio

SRPT0.95x

VIR6.51x

EV/Sales

SRPT1.09x

VIR5.59x

EV/EBITDA

SRPT12.13x

VIR1.92x

P/B Ratio

SRPT1.21x

VIR1.92x

P/FCF Ratio

SRPT25.00x

VIRN/A

EV/FCF

SRPT28.66x

VIR-8.32x

PEG Ratio

SRPTN/A

VIRN/A

Forward P/E (NTM)

SRPT46.80x

VIRN/A

Forward P/S (NTM)

SRPT1.31x

VIR36.09x

Revenue (TTM)

SRPT$1.97B

VIR$303M

Revenue Growth (YoY)

SRPT-20.4%

VIR1496.1%

Forward Rev Growth

SRPT-23.2%

VIR-58.9%

Gross Margin (TTM)

SRPT67.5%

VIR100.0%

Operating Margin (TTM)

SRPT0.0%

VIR0.0%

EBITDA Margin (TTM)

SRPT7.5%

VIR-45.9%

Net Margin (TTM)

SRPT-6.9%

VIR-41.5%

FCF Margin (TTM)

SRPT3.8%

VIR-67.1%

Net Income (TTM)

SRPT$-137M

VIR$-126M

FCF (TTM)

SRPT$75M

VIR$-204M

EPS (TTM)

SRPT-$1.30

VIR-$0.75

ROE (TTM)

SRPT-996.0%

VIR-1486.0%

ROA (TTM)

SRPT-414.0%

VIR-1168.0%

ROIC (TTM)

SRPT-605.0%

VIR-1486.0%

Cash

SRPT$571M

VIR$279M

Debt

SRPT$848M

VIR$0

Net Cash/Debt

SRPT$-276M

VIR$279M

Current Ratio (TTM)

SRPT4.42x

VIR6.04x

Quick Ratio (TTM)

SRPT2.57x

VIR5.69x

Debt/Equity (TTM)

SRPT0.55x

VIR0.00x

Debt/Assets (TTM)

SRPT0.0%

VIR0.0%

Interest Coverage (TTM)

SRPTN/A

VIRN/A

Net Debt/EBITDA (TTM)

SRPT0.00x

VIR0.00x

Beta

SRPT0.46

VIR1.77

52W Performance

SRPT-23.7%

VIR93.4%

YTD Performance

SRPT-16.2%

VIR97.0%

% from 52W High

SRPT-27.7%

VIR-2.6%

% from 52W Low

SRPT21.6%

VIR143.0%

Asset Turnover (TTM)

SRPT0.60x

VIR0.28x

FCF Yield (TTM)

SRPT4.0%

VIR-10.3%

Earnings Yield (TTM)

SRPT-7.3%

VIR-6.4%

Dividend Yield (TTM)

SRPTN/A

VIRN/A

Rule of 40

SRPT-16.6

VIR1,428.9

EV/GP/RG

SRPTN/A

VIRN/A

Ticker research

View SRPT research View VIR research

Metric	SRPT Sarepta Therapeutics Inc	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$1.88B	$1.97B
Enterprise Value	$2.16B	$1.69B
Price	$17.85	$11.70
P/E Ratio	N/A	N/A
P/S Ratio	0.95x	6.51x
EV/Sales	1.09x	5.59x
EV/EBITDA	12.13x	1.92x
P/B Ratio	1.21x	1.92x
P/FCF Ratio	25.00x	N/A
EV/FCF	28.66x	-8.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	46.80x	N/A
Forward P/S (NTM)	1.31x	36.09x
Revenue & Growth
Revenue (TTM)	$1.97B	$303M
Revenue Growth (YoY)	-20.4%	1496.1%
Forward Rev Growth	-23.2%	-58.9%
Profitability
Gross Margin (TTM)	67.5%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	7.5%	-45.9%
Net Margin (TTM)	-6.9%	-41.5%
FCF Margin (TTM)	3.8%	-67.1%
Net Income (TTM)	$-137M	$-126M
FCF (TTM)	$75M	$-204M
EPS (TTM)	-$1.30	-$0.75
ROE (TTM)	-996.0%	-1486.0%
ROA (TTM)	-414.0%	-1168.0%
ROIC (TTM)	-605.0%	-1486.0%
Financial Health
Cash	$571M	$279M
Debt	$848M	$0
Net Cash/Debt	$-276M	$279M
Current Ratio (TTM)	4.42x	6.04x
Quick Ratio (TTM)	2.57x	5.69x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.46	1.77
52W Performance	-23.7%	93.4%
YTD Performance	-16.2%	97.0%
% from 52W High	-27.7%	-2.6%
% from 52W Low	21.6%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.28x
FCF Yield (TTM)	4.0%	-10.3%
Earnings Yield (TTM)	-7.3%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-16.6	1,428.9
EV/GP/RG	N/A	N/A
Ticker research	View SRPT research	View VIR research

Valuation

P/S Ratio

SRPT

0.95x

VIR

6.51x

EV/FCF

VIR

-8.32x

SRPT

28.66x

Growth & revenue

Revenue Growth TTM

VIR

1496.1%

SRPT

-20.4%

Forward Revenue Growth

SRPT

-23.2%

VIR

-58.9%

Profitability & performance

Gross Margin

VIR

100.0%

SRPT

67.5%

ROE

SRPT

-996.0%

VIR

-1486.0%

FCF Yield %

SRPT

4.0%

VIR

-10.3%

52-Week Performance

VIR

93.4%

SRPT

-23.7%

Detailed metrics comparison

SRPT

Sarepta Therapeutics Inc

VIR

Vir Biotechnology Inc

Market Cap

SRPT$1.88B

VIR$1.97B

Enterprise Value

SRPT$2.16B

VIR$1.69B

Price

SRPT$17.85

VIR$11.70

P/E Ratio

SRPTN/A

VIRN/A

P/S Ratio

SRPT0.95x

VIR6.51x

EV/Sales

SRPT1.09x

VIR5.59x

EV/EBITDA

SRPT12.13x

VIR1.92x

P/B Ratio

SRPT1.21x

VIR1.92x

P/FCF Ratio

SRPT25.00x

VIRN/A

EV/FCF

SRPT28.66x

VIR-8.32x

PEG Ratio

SRPTN/A

VIRN/A

Forward P/E (NTM)

SRPT46.80x

VIRN/A

Forward P/S (NTM)

SRPT1.31x

VIR36.09x

Revenue (TTM)

SRPT$1.97B

VIR$303M

Revenue Growth (YoY)

SRPT-20.4%

VIR1496.1%

Forward Rev Growth

SRPT-23.2%

VIR-58.9%

Gross Margin (TTM)

SRPT67.5%

VIR100.0%

Operating Margin (TTM)

SRPT0.0%

VIR0.0%

EBITDA Margin (TTM)

SRPT7.5%

VIR-45.9%

Net Margin (TTM)

SRPT-6.9%

VIR-41.5%

FCF Margin (TTM)

SRPT3.8%

VIR-67.1%

Net Income (TTM)

SRPT$-137M

VIR$-126M

FCF (TTM)

SRPT$75M

VIR$-204M

EPS (TTM)

SRPT-$1.30

VIR-$0.75

ROE (TTM)

SRPT-996.0%

VIR-1486.0%

ROA (TTM)

SRPT-414.0%

VIR-1168.0%

ROIC (TTM)

SRPT-605.0%

VIR-1486.0%

Cash

SRPT$571M

VIR$279M

Debt

SRPT$848M

VIR$0

Net Cash/Debt

SRPT$-276M

VIR$279M

Current Ratio (TTM)

SRPT4.42x

VIR6.04x

Quick Ratio (TTM)

SRPT2.57x

VIR5.69x

Debt/Equity (TTM)

SRPT0.55x

VIR0.00x

Debt/Assets (TTM)

SRPT0.0%

VIR0.0%

Interest Coverage (TTM)

SRPTN/A

VIRN/A

Net Debt/EBITDA (TTM)

SRPT0.00x

VIR0.00x

Beta

SRPT0.46

VIR1.77

52W Performance

SRPT-23.7%

VIR93.4%

YTD Performance

SRPT-16.2%

VIR97.0%

% from 52W High

SRPT-27.7%

VIR-2.6%

% from 52W Low

SRPT21.6%

VIR143.0%

Asset Turnover (TTM)

SRPT0.60x

VIR0.28x

FCF Yield (TTM)

SRPT4.0%

VIR-10.3%

Earnings Yield (TTM)

SRPT-7.3%

VIR-6.4%

Dividend Yield (TTM)

SRPTN/A

VIRN/A

Rule of 40

SRPT-16.6

VIR1,428.9

EV/GP/RG

SRPTN/A

VIRN/A

Ticker research

View SRPT research View VIR research

Metric	SRPT Sarepta Therapeutics Inc	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$1.88B	$1.97B
Enterprise Value	$2.16B	$1.69B
Price	$17.85	$11.70
P/E Ratio	N/A	N/A
P/S Ratio	0.95x	6.51x
EV/Sales	1.09x	5.59x
EV/EBITDA	12.13x	1.92x
P/B Ratio	1.21x	1.92x
P/FCF Ratio	25.00x	N/A
EV/FCF	28.66x	-8.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	46.80x	N/A
Forward P/S (NTM)	1.31x	36.09x
Revenue & Growth
Revenue (TTM)	$1.97B	$303M
Revenue Growth (YoY)	-20.4%	1496.1%
Forward Rev Growth	-23.2%	-58.9%
Profitability
Gross Margin (TTM)	67.5%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	7.5%	-45.9%
Net Margin (TTM)	-6.9%	-41.5%
FCF Margin (TTM)	3.8%	-67.1%
Net Income (TTM)	$-137M	$-126M
FCF (TTM)	$75M	$-204M
EPS (TTM)	-$1.30	-$0.75
ROE (TTM)	-996.0%	-1486.0%
ROA (TTM)	-414.0%	-1168.0%
ROIC (TTM)	-605.0%	-1486.0%
Financial Health
Cash	$571M	$279M
Debt	$848M	$0
Net Cash/Debt	$-276M	$279M
Current Ratio (TTM)	4.42x	6.04x
Quick Ratio (TTM)	2.57x	5.69x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.46	1.77
52W Performance	-23.7%	93.4%
YTD Performance	-16.2%	97.0%
% from 52W High	-27.7%	-2.6%
% from 52W Low	21.6%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.28x
FCF Yield (TTM)	4.0%	-10.3%
Earnings Yield (TTM)	-7.3%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-16.6	1,428.9
EV/GP/RG	N/A	N/A
Ticker research	View SRPT research	View VIR research